Free Trial

Molecular Templates (MTEM) SEC Filings & 10K Form

Molecular Templates logo
$0.37 -0.02 (-4.64%)
(As of 02:16 PM ET)

Recent Molecular Templates SEC Filings

DateFilerForm TypeView
11/18/2024
8:49 PM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
11/18/2024
8:12 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
5:05 AM
Molecular Templates (Filer)
Form NT 10-Q
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
10/28/2024
4:20 PM
Molecular Templates (Filer)
Form DEF 14A
10/17/2024
4:05 PM
Molecular Templates (Filer)
Form PRE 14A
10/11/2024
3:39 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:02 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
4:35 PM
Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:36 PM
HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:36 PM
Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:37 PM
Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:41 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:01 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:36 PM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
3:26 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:43 PM
Molecular Templates (Filer)
Form DEF 14A
08/13/2024
3:44 PM
Molecular Templates (Filer)
Form DEFA14A
08/13/2024
3:47 PM
Molecular Templates (Filer)
Form ARS
06/03/2024
7:13 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:18 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:21 PM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2024
11:15 PM
Molecular Templates (Filer)
Form EFFECT
04/29/2024
8:51 PM
Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
Form SC 13D/A
04/25/2024
3:33 PM
Molecular Templates (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/12/2024
3:22 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:13 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:57 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
8:56 PM
Molecular Templates (Subject)
SANTE HEALTH VENTURES I LP (Filed by)
Form SC 13D/A
03/29/2024
3:06 PM
Molecular Templates (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
7:57 AM
Molecular Templates (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2024
7:45 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:22 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:08 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:39 PM
Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
02/14/2024
3:45 PM
K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/14/2024
8:33 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/13/2024
10:00 AM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
01/25/2024
4:32 PM
Molecular Templates (Issuer)
Poma Eric E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:34 PM
Kim Jason S. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:49 PM
Molecular Templates (Issuer)
Voi Maurizio (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
2024 Election Year Stocks: Uncover Hidden Gems! (Ad)

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MTEM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners